Our product
Lieberty logo
liberty product
liberty product

Our innovative solution diagnoses and monitors respiratory infections in patients within hospital and nursing home rooms, as well as in hospital at home settings.

Providing real-time, noninvasive bedside detection and monitoring, the system aims to indentify the pathogen involved for both inpatient and outpatient care.

Noninvasive diagnostic &
monitoring of respiratory infections

Identification of the pathogen involved
(coming soon)

Bedside use in hospitals,
nursing homes & home settings

Assessment of antibiotic efficacy
(coming soon)

Oversight of patients to prevent
hospital-acquired respiratory infections

Remote monitoring of patients
hospitalized at home

Unmet medical need.


> Rapid etiological orientation to deliver the adequate antibiotic therapy

> Supervise the progression and resolution of the infection, ensuring faster discharge

> Timely assessment of antibiotics’ efficacy

> Monitor patients to prevent hospital acquired respiratory infections


> Diagnostic and prognostic for individuals without access to laboratory tests

> Monitor patients hospitalized at home

Disclaimer: Not CE-marked. Product not available on the market, not for sale.

Read more

Easy to use & self-installation

Patient centric diagnostic solution for respiratory infections

Detect novel gas biomarkers in breath

Identification of the pathogen involved (coming soon)

Noninvasive & continuous monitoring

Early detection through the application of volatolomics

Real-time Data Analytics

AI & cloud-based algorithm

Diagnostic results on hospital platform (coming soon)

Reduce antibiotic consumption

Address Antimicrobial Resistance (AMR)

Reduce cost of care

Enable remote monitoring of patients hospitalized at home